Physician profile
Daniel Rothstein
NPI 1063707065
$724.27
in general payments reported to CMS, 2019-2025
23 companies · $19.08 in 2025
The $19.08 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $179 · 2021: $153 · 2022: $91.73 · 2023: $31.89 · 2024: $115 · 2025: $19.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $165.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $118.41 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $75.93 | 2022-2024 | Bridion |
| Pfizer INC. | $70.17 | 2019-2020 | |
| Abbott Laboratories | $56.74 | 2019-2020 | |
| Edwards Lifesciences Corporation | $34.78 | 2024 | Hemosphere |
| Baxter Healthcare | $34.63 | 2022 | |
| Tersera Therapeutics LLC | $29.40 | 2019 | |
| Biodelivery Sciences International, INC. | $29.37 | 2020 | |
| Boston Scientific Corporation | $28.98 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $28.73 | 2020 | |
| Ambu INC. | $25.20 | 2024 | |
| Medtronic, INC. | $24.23 | 2021 | |
| Nevro Corp. | $23.64 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $21.79 | 2024 | Exparel |
| Janssen Biotech, INC. | $19.08 | 2025 | Tremfya |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $15.94 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.09 | 2024 | Entyvio |
| Collegium Pharmaceutical, INC. | $14.00 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.41 | 2019 | |
| Baudax Bio INC. | $12.98 | 2020 | |
| Lilly USA, LLC | $12.18 | 2019 | |
| Kaleo, INC. | $10.95 | 2019 | |
| Spr Therapeutics, INC | $8.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Rothstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.